Transcription factors

被引:18
作者
Handel, ML
Girgis, L
机构
[1] Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia
[2] Univ New S Wales, Darlinghurst, NSW 2010, Australia
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2001年 / 15卷 / 05期
关键词
nuclear factor-kappa B (NF-kappa B); activator protein-1(AP-I); signal transducers and activators of transcription (STATs); nuclear factors of activated T cells (NFATs); glucocorticold receptor (GR); retinoid X receptor (RXR); peroxisome proliferator-activated receptors (PPARs);
D O I
10.1053/berh.2001.0186
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The regulation of gene expression by transcription factors is fundamental to the phenotype of all cells. The activated phenotype of cells engaged in inflammatory processes is characterized by induced expression of a diverse set of genes, including cytokines, enzymes and cell adhesion molecules. A relatively small number of inducible transcription factors, particularly NF-kappaB, AP-1, NFATs and STATs, are responsible for the expression of a wide variety of inflammatory phenotypic characteristics and therefore play a central role in the pathogenesis of rheumatic diseases. Each of these transcription factors can be modified by existing anti-rheumatic and anti-inflammatory drugs, although adverse effects and limited efficacy remain problems. The future development of therapeutic agents with specificity for transcription factors, especially NF-kappaB, might lead to safer and more effective treatment.
引用
收藏
页码:657 / 675
页数:19
相关论文
共 119 条
[1]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[2]   IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS [J].
AUPHAN, N ;
DIDONATO, JA ;
ROSETTE, C ;
HELMBERG, A ;
KARIN, M .
SCIENCE, 1995, 270 (5234) :286-290
[3]  
Aupperle KR, 1999, J IMMUNOL, V163, P427
[4]   The transcription factor NF-κB and human disease [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (01) :3-6
[5]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[6]   EMBRYONIC LETHALITY AND LIVER DEGENERATION IN MICE LACKING THE RELA COMPONENT OF NF-KAPPA-B [J].
BEG, AA ;
SHA, WC ;
BRONSON, RT ;
GHOSH, S ;
BALTIMORE, D .
NATURE, 1995, 376 (6536) :167-170
[7]   Defining therapeutic targets by using adenovirus:: Blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators [J].
Bondeson, J ;
Foxwell, B ;
Brennan, F ;
Feldmann, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5668-5673
[8]   Effects of anti-rheumatic gold salts on NF-κB mobilization and tumour necrosis factor-alpha (TNF-α)-induced neutrophil-dependent cytotoxicity for human endothelial cells [J].
Bratt, J ;
Belcher, J ;
Vercellotti, GM ;
Palmblad, J .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (01) :79-84
[9]   JOINT DESTRUCTION IN ARTHRITIS - METALLOPROTEINASES IN THE SPOTLIGHT [J].
BRINCKERHOFF, CE .
ARTHRITIS AND RHEUMATISM, 1991, 34 (09) :1073-1075
[10]   Glucocorticoid-mediated repression of NF kappa B activity in endothelial cells does not involve induction of I kappa B alpha synthesis [J].
Brostjan, C ;
Anrather, J ;
Csizmadia, V ;
Stroka, D ;
Soares, M ;
Bach, FH ;
Winkler, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19612-19616